OA09121A - Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant. - Google Patents
Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant.Info
- Publication number
- OA09121A OA09121A OA59600A OA59600A OA09121A OA 09121 A OA09121 A OA 09121A OA 59600 A OA59600 A OA 59600A OA 59600 A OA59600 A OA 59600A OA 09121 A OA09121 A OA 09121A
- Authority
- OA
- OAPI
- Prior art keywords
- pharmaceutical compositions
- preparation process
- compositions containing
- strontium salt
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Light Receiving Elements (AREA)
- Cephalosporin Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8808729A FR2633619B1 (fr) | 1988-06-29 | 1988-06-29 | Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA09121A true OA09121A (fr) | 1991-10-31 |
Family
ID=9367847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA59600A OA09121A (fr) | 1988-06-29 | 1989-06-28 | Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4939164A (pt) |
| EP (1) | EP0349432B1 (pt) |
| JP (1) | JPH0248567A (pt) |
| AT (1) | ATE81118T1 (pt) |
| AU (1) | AU613297B2 (pt) |
| CA (1) | CA1312333C (pt) |
| DE (1) | DE68903059T2 (pt) |
| DK (1) | DK325289A (pt) |
| ES (1) | ES2044170T3 (pt) |
| FR (1) | FR2633619B1 (pt) |
| GR (1) | GR3006674T3 (pt) |
| IE (1) | IE64112B1 (pt) |
| NZ (1) | NZ229760A (pt) |
| OA (1) | OA09121A (pt) |
| PT (1) | PT91006B (pt) |
| ZA (1) | ZA894945B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7404967B2 (en) * | 1994-12-21 | 2008-07-29 | Cosmederm, Inc. | Topical product formulations containing strontium for reducing skin irritation |
| FR2749759B1 (fr) * | 1996-06-17 | 1999-11-26 | Adir | Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose |
| ATE342722T1 (de) * | 2003-05-07 | 2006-11-15 | Osteologix As | Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen |
| AU2004237438B2 (en) * | 2003-05-07 | 2011-01-20 | Osteologix A/S | Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions |
| PL1732575T3 (pl) | 2004-02-26 | 2011-05-31 | Osteologix As | Związki zawierające stron do stosowania w zapobieganiu lub leczeniu stanów nekrotycznych kości |
| JP5070046B2 (ja) | 2004-06-25 | 2012-11-07 | モクワロ エスペーエフ エス．アー． | ストロンチウムおよびビタミンｄを含む組成物およびその使用 |
| US7875627B2 (en) * | 2004-12-07 | 2011-01-25 | Abbott Laboratories | Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof |
| EP2530068A1 (en) | 2011-05-31 | 2012-12-05 | Lacer, S.A. | New strontium salts, synthesis and use thereof in the treatment of osteoporosis |
| AU2015333019B9 (en) | 2014-10-14 | 2018-11-29 | Unilever Plc | Spraying device |
| WO2016058753A1 (en) | 2014-10-14 | 2016-04-21 | Unilever N.V. | Device for spraying an enclosure triggered by inclination of a rotatable lid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2954384A (en) * | 1960-09-27 | Method for preparing kainic acid and its | ||
| DE3127275A1 (de) * | 1980-12-11 | 1983-01-27 | Leskovar, Peter, Dr.-Ing., 8000 München | "harnsteinaufloesende mittel" |
-
1988
- 1988-06-29 FR FR8808729A patent/FR2633619B1/fr not_active Expired - Lifetime
-
1989
- 1989-06-20 US US07/368,593 patent/US4939164A/en not_active Expired - Fee Related
- 1989-06-26 ZA ZA894945A patent/ZA894945B/xx unknown
- 1989-06-27 CA CA000604039A patent/CA1312333C/fr not_active Expired - Fee Related
- 1989-06-28 IE IE209489A patent/IE64112B1/en not_active IP Right Cessation
- 1989-06-28 AU AU37092/89A patent/AU613297B2/en not_active Ceased
- 1989-06-28 PT PT91006A patent/PT91006B/pt not_active IP Right Cessation
- 1989-06-28 NZ NZ229760A patent/NZ229760A/en unknown
- 1989-06-28 OA OA59600A patent/OA09121A/xx unknown
- 1989-06-29 DK DK325289A patent/DK325289A/da not_active Application Discontinuation
- 1989-06-29 ES ES89401861T patent/ES2044170T3/es not_active Expired - Lifetime
- 1989-06-29 DE DE8989401861T patent/DE68903059T2/de not_active Expired - Fee Related
- 1989-06-29 JP JP1168247A patent/JPH0248567A/ja active Granted
- 1989-06-29 AT AT89401861T patent/ATE81118T1/de not_active IP Right Cessation
- 1989-06-29 EP EP89401861A patent/EP0349432B1/fr not_active Expired - Lifetime
-
1992
- 1992-12-24 GR GR920403112T patent/GR3006674T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE68903059D1 (de) | 1992-11-05 |
| IE64112B1 (en) | 1995-07-12 |
| DK325289D0 (da) | 1989-06-29 |
| US4939164A (en) | 1990-07-03 |
| DE68903059T2 (de) | 1993-04-29 |
| PT91006B (pt) | 1994-11-30 |
| AU3709289A (en) | 1990-01-04 |
| FR2633619A1 (fr) | 1990-01-05 |
| EP0349432B1 (fr) | 1992-09-30 |
| IE892094L (en) | 1989-12-29 |
| GR3006674T3 (pt) | 1993-06-30 |
| ES2044170T3 (es) | 1994-01-01 |
| CA1312333C (fr) | 1993-01-05 |
| ATE81118T1 (de) | 1992-10-15 |
| NZ229760A (en) | 1991-06-25 |
| PT91006A (pt) | 1989-12-29 |
| FR2633619B1 (fr) | 1991-02-08 |
| DK325289A (da) | 1989-12-30 |
| EP0349432A1 (fr) | 1990-01-03 |
| JPH0248567A (ja) | 1990-02-19 |
| JPH0587064B2 (pt) | 1993-12-15 |
| AU613297B2 (en) | 1991-07-25 |
| ZA894945B (en) | 1990-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA848369B (en) | Pharmaceutical compositions containing bilobalid for the treatment of neuropathies | |
| PH23256A (en) | A process for the preparation of quinolone carboxylic acid derivatives | |
| EP0243002A3 (en) | Pharmaceutical composition for the treatment of periodontal diseases | |
| FR2670491B1 (fr) | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant. | |
| ATE130762T1 (de) | Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen. | |
| NO890259L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider. | |
| EP0376251A3 (en) | An anticoagulant substance obtained from urine | |
| SE7902742L (sv) | Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav | |
| OA09121A (fr) | Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant. | |
| FR2618331B1 (fr) | Compositions pharmaceutiques utiles pour le traitement de l'uremie | |
| IL88971A (en) | Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them | |
| SE8703632L (sv) | For fordrojd frigivning anordnad fluoridkomposition | |
| ES2054089T3 (es) | Formulaciones orales liquidas. | |
| ZA875847B (en) | Pharmaceutical compositions for the treatment of occlusive vascular diseases | |
| NO156900C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater. | |
| FR2614203B1 (fr) | Composition pharmaceutique pour le traitement des maladies de la peau et son procede de preparation. | |
| EP0009636A3 (en) | 3-chloro-6-hydroxy-5-methylbenzoic acid derivative, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds in the treatment and prophylaxis of diseases and for promoting growth of certain animals, and their manufacture | |
| FR2600256B1 (fr) | Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus | |
| DE3162277D1 (en) | N-(4-phenyl-2-thiazolyl)-oxamidic-acid-2-ethoxyethylester, process for its preparation and pharmaceutical compositions containing this compound | |
| HUT50633A (en) | Process for producing pharmaceutical compositions comprising 1,4-dihydropyridine derivatives | |
| YU262380A (en) | Process for obtaining piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrol-2-carboxylic acid | |
| DK0538690T3 (da) | Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler | |
| ATA67688A (de) | Neue 3-(2-haloalkyl)-1,4-oxathiine und 2-(2-halo- alkyl)-1,4-dithiine sowie pharmazeutische zusammensetzungen mit diesen verbindungen zur behandlung von leukaemie und tumoren | |
| HU895238D0 (en) | Process for the preparation of pharmaceutical composition suitable for the treatment of pyogenous skin diseases | |
| HU895239D0 (en) | Process for the preparation of pharmaceutical compositions suitable for the treatment of skin diseases |